| Literature DB >> 22238571 |
Stephanie Franzkowiak1, Bettina Pollok, Katja Biermann-Ruben, Martin Südmeyer, Jennifer Paszek, Götz Thomalla, Melanie Jonas, Michael Orth, Alexander Münchau, Alfons Schnitzler.
Abstract
BACKGROUND: In Gilles de la Tourette syndrome (GTS) increased activation of the primary motor cortex (M1) before and during movement execution followed by increased inhibition after movement termination was reported. The present study aimed at investigating, whether this activation pattern is due to altered functional interaction between motor cortical areas. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 22238571 PMCID: PMC3251574 DOI: 10.1371/journal.pone.0027850
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical data.
| YGTSS | Tic-count: Tics/min | Medication | |||||||||||||||||
|
| |||||||||||||||||||
| Onset | motor | Total | Arm/ | Hand/ | Hip/ | Drug free | |||||||||||||
| Patient | Age | Sex | (age) | DCI | MRVS | total | tics | score | number | Face | Head | Shoulder | Finger | Body | Legs | complex | Vocal | Substance | since |
| P01 | 38 | m | 6 | 41 | 15 | 64 | 34 | 16 | 69 | 21,7 | 4,3 | 0 | 2,9 | 2,9 | 7,2 | 2,9 | 58,0 | naïve | - |
| P02 | 28 | m | 6 | 63 | 14 | 49 | 29 | 18 | 62 | 54,8 | 22,6 | 4,8 | 1,6 | 0,0 | 4,8 | 8,1 | 3,2 | T, P | >10 years |
| P03 | 28 | f | 8 | 36 | 6 | 9 | 9 | 9 | 35 | 60,0 | 0,0 | 11,4 | 17,1 | 0 | 5,7 | 5,7 | 0,0 | T | >5 years |
| P04 | 42 | f | 3 | 76 | 13 | 42 | 22 | 17 | 63 | 38,1 | 22,2 | 3,2 | 1,6 | 1,6 | 7,9 | 1,6 | 23,8 | D | >1 year |
| P05 | 54 | m | 13 | 57 | 15 | 49 | 19 | 11 | 68 | 10,3 | 22,1 | 19,1 | 4,4 | 14,7 | 10,3 | 7,4 | 11,8 | H | >10 years |
| P06 | 38 | m | 11 | 45 | 6 | 22 | 12 | 9 | 15 | 80,0 | 13,3 | 0 | 0 | 0,0 | 0,0 | 0 | 6,7 | T, P, C | >2 years |
| P07 | 25 | m | 5 | 67 | 7 | 29 | 19 | 13 | 41 | 51,2 | 14,6 | 12,2 | 12,2 | 0,0 | 7,3 | 2,4 | 0 | naïve | - |
| P08 | 39 | m | 12 | 100 | 14 | 77 | 37 | 23 | 55 | 54,5 | 3,6 | 1,8 | 18,2 | 0,0 | 3,6 | 3,6 | 14,5 | T, S | >6 month |
| P09 | 43 | m | 5 | 67 | 11 | 60 | 30 | 16 | 65 | 50,8 | 20,0 | 15,4 | 0 | 4,6 | 3,1 | 0 | 6,2 | T, S | >2 years |
| P10 | 22 | m | 11 | 34 | 12 | 35 | 15 | 15 | 27 | 74,1 | 7,4 | 0 | 11,1 | 0 | 7,4 | 0 | NA | naïve | - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
*no sound in the videotape.
m = male, f = female; MRVS = total score of Modiefied Rush Videotape Rating Scale, Tic-count: tics per minute on video.
Total number = all tic counted; relative tic number (%) = all tics related to the respective muscle groups.
Medication: C = Clonidin, D = Dronabinol, H = Haloperidol, P = Pimozid, S = Sulpirid, T = Tiaprid.
Figure 1Mean localizations of all identified sources for control subjects (left) and GTS-patients (right).
Please note that SPM99 has been used for visualization of mean source localizations only and does not provide any statistical comparison between groups.
Talairach coordinates.
| x-coordinate | y-coordinate | z-coordinate | |||
| Source | Group | (mm) | (mm) | (mm) | BA |
| M1 contralateral | controls (n = 10) | −36 | −22 | 50 | 4 |
| GTS (n = 10) | −38 | −18 | 58 | 4 | |
| M1 ipsilateral | controls (n = 10) | 44 | −20 | 48 | 3 |
| GTS (n = 10) | 42 | −16 | 44 | 4 | |
| PMC contralateral | controls (n = 9) | −40 | 0 | 60 | 6 |
| GTS (n = 10) | −36 | 14 | 56 | 6 | |
| PPC contralateral | controls (n = 10) | −50 | −36 | 58 | 40 |
| GTS (n = 10) | −44 | −60 | 42 | 39 | |
| SMA | controls (n = 9) | 10 | −14 | 72 | 6 |
| GTS (n = 9) | 6 | −8 | 60 | 6 | |
| Thalamus contralateral | controls (n = 10) | 0 | −16 | 4 | |
| GTS (n = 10) | −6 | −20 | 4 | ||
| Cerebellum ispilateral | controls (n = 10) | 42 | −72 | −44 | |
| GTS (n = 8) | 32 | −86 | −38 |
Figure 2Coherence spectra between SMA and M1 of one representative GTS-patient (black) and one control subject (grey).
The arrows mark the peak maxima (A). Mean M1-SMA coherence strength in GTS-patients (black) and healthy control subjects (grey; B). Error bars indicate SEM.